U.S. market Closed. Opens in 15 hours 30 minutes

MRVI | Maravai LifeSciences Holdings, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for MRVI we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is very good and Health is passable.

Valuation (62%)

Company Industry
P/E Ratio (TTM) -3.36 -20.30
PEG Ratio (TTM) 0.05 -5.71
P/S Ratio (TTM) 2.73 50.88
P/B Ratio (TTM) 2.19 29.28
P/FCF Ratio (TTM) -70.56 -8.95
Price to 5YR AVG Earnings Ratio 3.48 -6.52
Price to 5YR AVG FCF Ratio 3.54 -14.78

Profitability (25%)

Company Industry
ROA (TTM) -17.58% -18.85%
ROE (TTM) -55.83% 25.35%
Net Profit Margin (TTM) -81.13% -827.80%
ROIC 5YR AVG 54.05% -26.10%

Growth (77%)

4QTR AVG 3YR AVG 5YR AVG
EPS -639.92% 690.45% 387.68%
Revenue 0.16% 98.46% 47.72%
Net Income -654.91% 719.77% 407.92%
Cash Flow 6.89% 4,579.44% 2,741.46%

Health (60%)

Company Industry
Current Ratio (TTM) 10.74 6.09
Quick Ratio (TTM) 9.94 5.87
D/E Ratio (TTM) 1.51 1.00
Interest Coverage (TTM) -3.77 -9.57
Piotroski F-Score 3 4
Altman Z-Score 3.19 13.84
LTL to 5YR AVG FCF 2.80 0.07
Shares Outstanding Growth 5YR AVG 8.46% 44.11%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙